Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia

Guardado en:

Detalles Bibliográficos
Autores principales:	Colin Vercueil, Lauriane Eberst, Catherine Humbrecht, Luc-Matthieu Fornecker
Formato:	article
Lenguaje:	EN
Publicado:	Wolters Kluwer 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/9a56ac43367c4b45b8777131353a62f9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9a56ac43367c4b45b8777131353a62f9
record_format	dspace
spelling	oai:doaj.org-article:9a56ac43367c4b45b8777131353a62f92021-11-25T07:58:35ZEfficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia2572-924110.1097/HS9.0000000000000655https://doaj.org/article/9a56ac43367c4b45b8777131353a62f92021-12-01T00:00:00Zhttp://journals.lww.com/10.1097/HS9.0000000000000655https://doaj.org/toc/2572-9241Colin VercueilLauriane EberstCatherine HumbrechtLuc-Matthieu ForneckerWolters KluwerarticleDiseases of the blood and blood-forming organsRC633-647.5ENHemaSphere, Vol 5, Iss 12, p e655 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the blood and blood-forming organs RC633-647.5
spellingShingle	Diseases of the blood and blood-forming organs RC633-647.5 Colin Vercueil Lauriane Eberst Catherine Humbrecht Luc-Matthieu Fornecker Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
format	article
author	Colin Vercueil Lauriane Eberst Catherine Humbrecht Luc-Matthieu Fornecker
author_facet	Colin Vercueil Lauriane Eberst Catherine Humbrecht Luc-Matthieu Fornecker
author_sort	Colin Vercueil
title	Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
title_short	Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
title_full	Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
title_fullStr	Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
title_full_unstemmed	Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
title_sort	efficacy of serotherapy on an n501y variant of sars-cov-2 in a patient with chronic lymphocytic leukemia
publisher	Wolters Kluwer
publishDate	2021
url	https://doaj.org/article/9a56ac43367c4b45b8777131353a62f9
work_keys_str_mv	AT colinvercueil efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia AT laurianeeberst efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia AT catherinehumbrecht efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia AT lucmatthieufornecker efficacyofserotherapyonann501yvariantofsarscov2inapatientwithchroniclymphocyticleukemia
_version_	1718413574369443840

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia

Ejemplares similares